Medical Device Regulatory Challenges in India
For overseas medical device manufacturers in India, entering the Indian medical device market requires more than regulatory clearance from the Central Drugs Standard Control Organization (CDSCO). The Indian medical device regulation ecosystem involves multiple authorities, each with its own compliance requirements. These include:
NPPA (National Pharmaceutical Pricing Authority) for price control
Legal Metrology for labeling and MRP declaration
CPCB (Central Pollution Control Board) for Electronic and Plastic Waste regulations
Ministry of Environment for packaging-related compliance
FEMA (Foreign Exchange Management Act) for financial structuring and profit repatriation
Customs authorities for goods valuation, and duties
Advertising laws and codes (UCPMP, DMR Act) for promotional restrictions
At Morulaa HealthTech, we assist manufacturers in understanding these various India medical device regulations and manage product registration, compliance documentation, and post-market obligations.
What are the common challenges a manufacturer faces when they are looking to enter India? Some of the common ones are as below
1. Regulatory Documentation Gaps: DMF and PMF
Indian submissions require highly detailed and structured documentation. Manufacturers often need to reformat or expand their existing documents to meet the CDSCO medical device registration India expectations. For example,
The Device Master File (DMF) must include the below details:
Manufacturing flowchart
Clinical trial or published data
Biocompatibility reports
Physiochemical tests
Risk Management Report
Essential Principles Checklist
Quality control for raw and finished products
The Plant Master File (PMF) must include the below details:
Manufacturing site layout
Process flow and QA/QC systems
Organization structure
Plant registration certificate from the National Regulatory Authority (NRA).
2. Process Validation and Biocompatibility Data
Manufacturers often submit only high-level protocols for other international market approvals, however, medical device approval in India requires additional details such as simulated use, mechanical stress, and animal feasibility testing in the process validation report. Additionally, the Summary results must include the following - Bioburden testing, Pyrogen and sterility residue data and Packaging validation ISO 11607. For Biocompatibility reports, full reports and not summaries are required for cytotoxicity, sensitization, systemic toxicity, subchronic toxicity, genotoxicity, implantation, hemocompatibility, etc.
3. Shelf Life Evidence
Both accelerated and real-time aging studies must be submitted. Submitting only one is not sufficient for approval and the CDSCO will raise a query for the same.
4. Product Classification & Grouping Issues
CDSCO expects products grouped under one application to
Have the same intended use
Have the same material of construction
Have the same design
Additionally, the CDSCO released an FAQ stating that the products which come under the same brand name would be considered to be one family, else, separate CDSCO fees would have to be paid. For example, previously, an orthopaedic manufacturer could register their implants - plates, burrs and screws under one family in India. But now, the applicant needs to apply for them separately, increasing the cost of CDSCO fees.
5. Power of Attorney and Legalisation Issues
The manufacturer’s name should match across the Form 40, FSC, Schedule D(I), and POA. In terms of the article numbers and pack sizes, they must match the Free Sale Certificate and CDSCO forms. Additionally, The POA must be apostilled, not just notarized
6. Labeling & Predicate Device Evidence
The CDSCO mandates a predicate device comparison chart, which directly impacts the timelines for approval. Basically, if the product does not have an identical predicate, the manufacturer must be prepared that they will have to go through the MD-26 pathway wherein the CDSCO will decide if trials will be required and if yes, what the pathway would be. If a predicate and GHTF Approval (Approval from US, Canada Japan, Australia, EU, UK) is available, then the process is relatively straightforward and takes 6-9 months to get approved.
As per the Legal Meteorology (Packaged Commodity) Rules, 2011 an India specific artwork must include the below:
Importer Details
Import License Number
Month/ Year of Import
Maximum Retail Price (MRP)
This label can be customized based on the Manufacturer and Morulaa can support in creating a template for the same.
7. Certificates and Validity Criteria
When a manufacturer prepares the documents for medical device registration in India, they need to ensure that all certificates (e.g., FSC, DoC) must be valid for at least six months at the time of submission and must also keep in mind that CE Design Certificates are not accepted for Class I and II devices. Additionally, each product must have its own DoC with risk classification, printed on the manufacturer’s letterhead and signed by authorized personnel.
8. Price Control by NPPA
As per the National Pharmaceutical Pricing Authority (NPPA), all medical devices companies in India must follow the below:
Devices on the NPPA’s Schedule list are subject to ceiling prices.
Even non-scheduled devices cannot exceed a 10% price increase annually.
NPPA has authority to fix prices in public interest, affecting manufacturers' selling price in the market.
For example, if you are selling Stents into India, there is a cap at which they can be sold. For more information, click here.
9. Clinical Investigation and Post-Market Data
For Class C and D devices, CDSCO may demand Local clinical investigations unless the device has
Two years of post-market use in India or
An equivalent model already approved in India.
The Evidence must include Indian sales data or global post-market surveillance data.
10. Import Duties and Valuation
Import duties and valuation play an important role when importing medical devices into India. Devices are subject to varying rates of import duty, typically ranging from 0% to 28%, depending on how the product is classified under the Harmonized System of Nomenclature (HSN) code. The HSN code determines the specific category a product falls under, which directly impacts the applicable rate of customs duty. The declared value of the imported goods must be genuine and fully supported by appropriate documentation, such as purchase invoices, shipping documents, and product catalogs. If customs authorities detect any discrepancies or suspect that the product has been undervalued or misclassified, they have the authority to delay clearance, reassess the shipment, impose fines or penalties, or even mandate that the goods be returned to the country of origin. Therefore, at the time of customs clearance, all importers must be fully prepared to justify the pricing and classification of their products with proper documentation and transparency to avoid delays and complications.
11. Foreign Exchange Compliance (FEMA)
Invoicing and payments between overseas companies and Indian partners must be in accordance with FEMA regulations. Repatriation of funds requires clear documentation and a transparent transaction flow. Manufacturers should also factor in GST, TDS, and, where relevant, transfer pricing requirements
12. Promotional and Advertising Restrictions
The Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024 sets basic rules for how medical device manufacturers in India should promote their products. It bans giving gifts or other benefits to healthcare professionals and requires honest advertising and labeling. Companies must submit a yearly declaration confirming they follow the rules.
Why Work With Morulaa HealthTech
Morulaa HealthTech offers support to foreign medical device manufacturers in India. Our services address every medical device regulatory challenge in India outlined above:
Preparation and formatting of DMF, PMF, risk and test reports
POA legalisation, Schedule D(I), Form 40 alignment
Sterilization and biocompatibility test support and review
Label design, model mapping, and predicate comparison strategies
Pricing support and NPPA documentation
Customs classification and import duty advisories
FEMA-compliant invoicing and foreign exchange guidance
Clinical trial waiver application preparation
IP-safe handling of documentation and agency liaison
Acting as Indian Authorised Agent for CDSCO
Responding to CDSCO queries and post-approval compliance
We work across the US, Europe, Asia, and Oceania, ensuring documentation and strategies are fully in line with CDSCO medical device registration India expectations, while also supporting broader market access and distributor alignment.
Conclusion
How to get a medical device approved in India is a complex journey that involves much more than CDSCO licensing. The Indian medical device regulation framework is no longer limited to CDSCO compliance it spans pricing, environmental waste, packaging, foreign exchange, advertising restrictions, and more. Manufacturers who address only one part of the equation often face avoidable delays or rejection. With over a decade of experience, Morulaa HealthTech helps you navigate all challenges faced by foreign medical device manufacturers in India with the right documentation, strategies, and compliance support for smooth medical device registration in India.
Other posts